Ruba Kado

No ORCID on file · 1 paper in corpus

review 2019

Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus

·doi:10.1016/j.bpobgyn.2019.10.008

Administration of cyclophosphamide (CYC), an alkylating agent used to treat malignancies and severe rheumatic diseases, creates a risk of ovarian insufficiency that is related to the intensity and duration of therapy and the age of the pati…